增长激素释放激素受体 (GHRH-R) 和它的信号传递
Gabor Halmos1,2, Zsuzsanna Szabo3, Nikoletta Dobos3
1Department of Biopharmacy, Faculty of Pharmacy, University of Debrecen, Rex u. 10, Debrecen, 4032, Hungary. halmos.gabor@pharm.unideb.hu.
Reviews in endocrine & metabolic disorders
|February 11, 2025
概括
增长激素释放激素 (GHRH) 和它的受体 (GHRH-R) 在激素分泌中发挥关键作用. 研究探讨了GHRH-R拼接变体及其在各种疾病中的治疗潜力.
科学领域:
- 内分泌学和分子生物学
- G蛋白结合受体 (GPCR) 的研究.
背景情况:
- 增长激素释放激素 (GHRH) 通过GHRH受体 (GHRH-R) 刺激垂体生长激素 (GH) 的分泌.
- GHRH-R是一种G蛋白结合受体,在各种组织中发现多种拼接变体 (SV),包括瘤.
- 拼接变体1 (SV1) 与全长的GHRH-R非常相似,并保留了功能信号 (cAMP,线粒生成).
研究的目的:
- 审查GHRH-Rs及其SVs的激活,调节,分子机制和信号通路.
- 要总结GHRH,其类似物和受体的表达,生物活动和潜在功能.
- 评估GHGH激动剂和对抗剂的潜在临床应用.
主要方法:
- 关于GHRH,GHRH-R及其拼接变体的现有研究的文献综述.
- 对GHRH-R拼接变体的cDNA测序数据的分析.
- 综合了关于信号通路,生物活动和临床评估的发现.
主要成果:
- 存在GHRH-R拼接变体,并且可以是功能性的,SV1与全长受体具有显著的相似性和活性.
- GHRH及其类型在各种治疗领域都显示出潜力.
- 广泛的研究支持评估基于GHGH的疗法.
结论:
- GHRH-R及其拼接变体是GHRH信号传递的组成部分,其影响超出了垂体.
- GHRH类型的多样化生物活性表明其具有广泛的治疗效用.
- 对于未来在人体医学中的临床应用,GHGH类型显示出显著的前景.
相关概念视频
Endocrine Signaling
63.9K
Endocrine cells produce hormones to communicate with remote target cells found in other organs. The hormone reaches these distant areas using the circulatory system. This exposes the whole organism to the hormone but only those cells expressing hormone receptors or target cells are affected. Thus, endocrine signaling induces slow responses from its target cells but these effects also last longer.
63.9K
Insulin: The Receptor and Signaling Pathways
1.1K
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
1.1K
Secondary Messengers in Hormone Action
2.0K
Water-soluble hormones cannot cross the plasma membrane, so they rely on protein receptors that span the membrane to trigger intracellular signaling pathways. These pathways then activate second messengers inside the cell, including cAMP or calcium ions.
Many hormones bind to transmembrane G protein-coupled receptors that connect to regulatory G proteins. These G proteins can then activate enzymes such as adenylyl cyclase or phospholipase C. Adenylyl cyclase converts ATP to cAMP, activating...
Many hormones bind to transmembrane G protein-coupled receptors that connect to regulatory G proteins. These G proteins can then activate enzymes such as adenylyl cyclase or phospholipase C. Adenylyl cyclase converts ATP to cAMP, activating...
2.0K
Cell-surface Signaling
51.4K
Hormones—or any molecule that binds to a receptor, known as a ligand—that are lipid-insoluble (water-soluble) are not able to diffuse across the cell membrane. In order to be able to affect a cell without entering it, these hormones bind to receptors on the cell membrane. When a first messenger, a hormone, binds to a receptor, a signal cascade is set off, causing second messengers, proteins inside the cell, to become activated, resulting in downstream effects.
51.4K
Regulation of Hormone Secretion
3.1K
Regulation of hormone secretion is a finely tuned orchestration driven by various types of stimuli, encompassing neural, humoral, and hormonal signals. Environmental cues instigate neural stimuli, where action potentials traverse nerve fibers to reach their designated targets. An illustrative scenario is the body's response to stress, wherein the sympathetic nervous system releases epinephrine from the adrenal glands, inducing the well-known 'fight or flight' reaction.
Humoral...
Humoral...
3.1K
TGF - β Signaling Pathway
7.2K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.2K


